VC firm Aglaia launches $65m oncology fund
This article was originally published in Scrip
Executive Summary
Dutch venture capital firm Aglaia Biomedical Ventures is aiming to finance 10-15 "high-potential" oncology start-ups following the launch of its new investment fund, Aglaia Oncology Fund II.